Literature DB >> 24215609

Antimicrobial resistance in Staphylococcus aureus, Streptococcus uberis and Streptococcus dysgalactiae from dairy cows with mastitis.

S McDougall1, H Hussein, K Petrovski.   

Abstract

AIMS: To determine the minimal inhibitory concentrations (MIC) of antimicrobials for common mastitis pathogens from dairy cows in New Zealand; and to assess the effect of source of the isolates, i.e. commercial veterinary laboratories or collected as part of research studies; the clinical status of the cow, i.e. subclinical or clinical mastitis; cow age and herd on the distribution of the MIC.
METHODS: Minimal inhibitory concentrations for Staphylococcus aureus (n=364), Streptococcus dysgalactiae (n=65) and Streptococcus uberis (n=102) isolated from milk samples from dairy cows were determined for a variety of antimicrobials using broth microdilution. Isolates of S. aureus were sourced from research studies from both subclinically (n=161) and clinically (n=104) affected cows, as well as from commercial veterinary laboratories (n=101); while all the streptococcal isolates were from commercial laboratories. Resistance was defined using the cut-points provided by the Clinical and Laboratory Standards Institute (CLSI).
RESULTS: The distribution of MIC varied among the bacterial species for every antimicrobial tested (p<0.001). Of the S. aureus isolates, 28, 2 and 0.5% were resistant to penicillin, ampicillin and trimethoprim/sulfamethoxazole, respectively. For S. dysgalactiae and S. uberis isolates, 17 and 13% were resistant to trimethoprim/sulfamethoxazole, respectively. One isolate (1%) of S. uberis was resistant to penicillin. The distribution of MIC of S. aureus varied with clinical status, between herds, and with age of cow (p<0.05). The distribution of MIC for S. aureus for penicillin, amoxicillin/clavulanic acid, cloxacillin and ampicillin were lower from clinical than subclinical cases, and those for amoxicillin/clavulanic acid and oxytetracycline from isolates from veterinary laboratories were lower than for those from research studies.
CONCLUSIONS: Resistance to some beta-lactam antimicrobials and trimethoprim/sulfamethoxazole were found in isolates from cases of bovine mastitis. The distribution of MIC for isolates of S. aureus varied with clinical status of the cow, the age of the cow, the herd and with the source of isolate. CLINICAL SIGNIFICANCE: Resistance to penicillin was found in a quarter of S. aureus isolates, but in virtually no Streptococcus isolates; therefore microbial identification and sensitivity testing would be beneficial when assessing treatment options. The source of the isolates affected the estimated MIC, suggesting that selection of isolates for monitoring of resistance requires care and that use of routine submissions to commercial laboratories to assess antimicrobial resistance patterns may result in biased estimates of prevalence of resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24215609     DOI: 10.1080/00480169.2013.843135

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  15 in total

1.  Assessment of animal diseases caused by bacteria resistant to antimicrobials: cattle.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Angel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Stahl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Jeroen Dewulf; Luca Guardabassi; Friederike Hilbert; Rodolphe Mader; Francesca Baldinelli; Julio Alvarez
Journal:  EFSA J       Date:  2021-12-10

2.  Translational studies on a ready-to-use intramuscular injection of penethamate for bovine mastitis.

Authors:  I G Tucker; R Jain; F Alawi; K Nanjan; O Bork
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

3.  Development and validation of a UPLC-MS/MS method to monitor cephapirin excretion in dairy cows following intramammary infusion.

Authors:  Partha Ray; Katharine F Knowlton; Chao Shang; Kang Xia
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

4.  A Novel Antimicrobial-Phytochemical Conjugate With Antimicrobial Activity Against Streptococcus uberis, Enterococcus faecium, and Enterococcus faecalis.

Authors:  Karthic Rajamanickam; Jian Yang; Meena Kishore Sakharkar
Journal:  Front Pharmacol       Date:  2019-11-28       Impact factor: 5.810

5.  Effects of Dietary Vibroactivated Clinoptilolite Supplementation on the Intramammary Microbiological Findings in Dairy Cows.

Authors:  Dražen Đuričić; Tomislav Sukalić; Franjo Marković; Predrag Kočila; Ivona Žura Žaja; Sven Menčik; Tomislav Dobranić; Miroslav Benić; Marko Samardžija
Journal:  Animals (Basel)       Date:  2020-01-25       Impact factor: 2.752

6.  Therapy of Subclinical Mastitis during Lactation.

Authors:  Scott McDougall; Laura M Clausen; Hassan M Hussein; Chris W R Compton
Journal:  Antibiotics (Basel)       Date:  2022-02-07

7.  Genotyping and Antimicrobial Susceptibility Profiling of Streptococcus uberis Isolated from a Clinical Bovine Mastitis Outbreak in a Dairy Farm.

Authors:  Valentina Monistero; Antonio Barberio; Paola Cremonesi; Bianca Castiglioni; Stefano Morandi; Desiree C K Lassen; Lærke B Astrup; Clara Locatelli; Renata Piccinini; M Filippa Addis; Valerio Bronzo; Paolo Moroni
Journal:  Antibiotics (Basel)       Date:  2021-05-28

8.  Antimicrobial Susceptibility Patterns of Environmental Streptococci Recovered from Bovine Milk Samples in the Maritime Provinces of Canada.

Authors:  Marguerite Cameron; Matthew Saab; Luke Heider; J Trenton McClure; Juan Carlos Rodriguez-Lecompte; Javier Sanchez
Journal:  Front Vet Sci       Date:  2016-09-15

9.  Comparative analysis of four commercial on-farm culture methods to identify bacteria associated with clinical mastitis in dairy cattle.

Authors:  Jair C Ferreira; Marilia S Gomes; Erika C R Bonsaglia; Igor F Canisso; Edgar F Garrett; Jamie L Stewart; Ziyao Zhou; Fabio S Lima
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

10.  A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms.

Authors:  Mariana Pérez-Ibarreche; Des Field; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.